Caption Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.81M Buy
+15,000
New +$3.5M 0.02% 669
2026
Q1
Sell
-362,300
Closed -$75M 1812
2025
Q4
$75M Buy
+362,300
New +$71.6M 0.51% 36
2025
Q1
Sell
-69,400
Closed -$10M 1798
2024
Q4
$10M Buy
+69,400
New +$10.8M 0.09% 196
2024
Q1
Sell
-100,000
Closed -$15.7M 1442
2023
Q4
$15.7M Buy
+100,000
New +$15.3M 0.21% 119
2023
Q3
Sell
-150,000
Closed -$24.8M 1395
2023
Q2
$24.8M Buy
150,000
+50,000
+50% +$8.07M 0.44% 40
2023
Q1
$15.5M Hold
100,000
0.3% 76
2022
Q4
$17.7M Sell
100,000
-200,000
-67% -$34.5M 0.28% 84
2022
Q3
$49M Buy
+300,000
New +$50.8M 0.68% 23
2022
Q2
Sell
-40,000
Closed -$7.09M 1644
2022
Q1
$7.09M Buy
+40,000
New +$6.81M 0.09% 317

Other funds holding JNJ

Caption Management's JNJ Position: Q2 2026 in Review

Caption Management reduced its Johnson & Johnson (JNJ) stake by 31% in Q2 2026, selling an estimated $6.42M and leaving 60,000 shares worth $15.2M. The position accounts for 0.07% of the portfolio, ranked #295.

Caption Management first reported a position in JNJ in Q3 2022 and has held it in 6 quarters since. The position peaked at $21.4M in Q1 2026. 4,680 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Caption Management held 60,000 shares of Johnson & Johnson worth $15.2M as of Q2 2026.
  • Caption Management sold 27,550 Johnson & Johnson shares in Q2 2026, an estimated $6.42M.
  • Johnson & Johnson made up 0.07% of Caption Management's portfolio in Q2 2026, its #295 holding.
  • Caption Management first reported a position in Johnson & Johnson in Q3 2022 and has held it in 6 quarters since.
  • Caption Management's Johnson & Johnson position peaked at $21.4M in Q1 2026.
  • 4,680 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.